Management of Individuals with CHEK2 Mutations

Excerpt from the October 2023 ICARE case conference featuring Dr. Helen Hanson from the University of Exeter (presenting on behalf of Dr. Douglas Stewart from the National Cancer Institute) reviewing management options for individuals with a CHEK2 pathogenic variant, including low penetrance variants.

Check out the ACMG clinical practice resource on CHEK2 here: https://www.gimjournal.org/article/S1.... This resource was developed through a group of worldwide experts including Dr. Hanson, Dr Stewart and ICARE's principal investigator Dr. Tuya Pal!

Follow us to stay informed on your favorite social media platform:
LinkedIn:   / inherited-cancer-registry  
Twitter:   / inheritedcancer  
Instagram:   / inheritedcancer  
Facebook:   / inheritedcancer